INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 450m ago
HOUSE PTR49m ago
SEC 13F49m ago
ROBINHOOD CHAIN49m ago
Corporate insider
SB

Spetzler David Baxley

PresidentCIK 0002071953

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells1 / 3
Max Insider Score50
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Option exercise
M$610K
250.0K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Caris Life Sciences, Inc.President · Nov 10, 2025
5
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Option exercise
M
—
250.0K sh
Sep 4, 2026
Sep 4, 2026
traded Sep 4, 2026
+0d
SEC FORM 4

Evidence

50
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$9.73M
393.1K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC FORM 4

Evidence

26
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Option exercise
M$2.44M
1.00M sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC FORM 4

Evidence

46
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$2.15M
84.9K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC FORM 4

Evidence

35
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$2.95M
119.2K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC FORM 4

Evidence

5
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Option exercise
M—
1.00M sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC FORM 4

Evidence

8
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Tax withholding
F$211K
13.9K sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC FORM 4

Evidence

9
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Grant or award
A—
83.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

34
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market purchase
BUY$9,540
400 sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC FORM 4

Evidence